Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GlaxoSmithKline plc
  6. News
  7. Analyst Reco.
    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Analyst Recommendations on GLAXOSMITHKLINE PLC
01/17GLAXOSMITHKLINE : Barclays reiterates its Neutral rating
MD
01/17GLAXOSMITHKLINE : JP Morgan remains Neutral
MD
01/17GLAXOSMITHKLINE : UBS reiterates its Neutral rating
MD
01/17GLAXOSMITHKLINE : Credit Suisse remains a Sell rating
MD
01/13GLAXOSMITHKLINE : JP Morgan reiterates its Neutral rating
MD
01/07GLAXOSMITHKLINE : Goldman Sachs keeps its Buy rating
MD
01/04JP Morgan Raises GlaxoSmithKline PT, Maintains Neutral Rating
MT
01/04GLAXOSMITHKLINE : JP Morgan sticks Neutral
MD
2021GLAXOSMITHKLINE : Goldman Sachs reaffirms its Buy rating
MD
2021GLAXOSMITHKLINE : Jefferies reaffirms its Buy rating
MD
2021GLAXOSMITHKLINE : Goldman Sachs reiterates its Buy rating
MD
2021GLAXOSMITHKLINE : Goldman Sachs reiterates its Buy rating
MD
2021GLAXOSMITHKLINE : Jefferies reiterates its Buy rating
MD
2021GLAXOSMITHKLINE : Deutsche Bank reaffirms its Neutral rating
MD
2021GLAXOSMITHKLINE : UBS remains Neutral
MD
2021GLAXOSMITHKLINE : UBS reiterates its Neutral rating
MD
2021GLAXOSMITHKLINE : Gets a Buy rating from Berenberg
MD
2021GLAXOSMITHKLINE : UBS remains Neutral
MD
2021GLAXOSMITHKLINE : UBS gives a Neutral rating
MD
2021Goldman Sachs Keeps GlaxoSmithKline At Buy, Lifts PT
MT
2021ANALYST RECOMMENDATIONS : Beyond Meat, HSBC, Pfizer, The Home Depot, Walt Disney...
2021GLAXOSMITHKLINE : Buy rating from Goldman Sachs
MD
2021GLAXOSMITHKLINE : UBS sticks Neutral
MD
2021UBS Lifts GlaxoSmithKline PT, Maintains Neutral Rating
MT
2021GLAXOSMITHKLINE : Gets a Buy rating from Goldman Sachs
MD
2021GLAXOSMITHKLINE : JP Morgan gives a Neutral rating
MD
2021GLAXOSMITHKLINE : Gets a Neutral rating from UBS
MD
2021Barclays Upgrades GSK To Equal-Weight From Underweight, Boosts PT
MT
2021ANALYST RECOMMENDATIONS : BP, GlaxoSmithKline, Nikola, Papa John's, Qualcomm...
2021Barclays Upgrades GlaxoSmithKline to Equalweight From Underweight
MT
2021GLAXOSMITHKLINE : Upgraded to Neutral by Barclays
MD
2021JPMorgan Lifts GlaxoSmithKline PT, Keeps Neutral Rating
MT
2021GLAXOSMITHKLINE : Gets a Neutral rating from JP Morgan
MD
2021GLAXOSMITHKLINE : Deutsche Bank sticks Neutral
MD
2021GLAXOSMITHKLINE : UBS remains Neutral
MD
2021Barclays Lifts GlaxoSmithKline PT, Keeps Underweight Rating
MT
2021GLAXOSMITHKLINE : Kepler Cheuvreux gives a Neutral rating
MD
2021GLAXOSMITHKLINE : Sell rating from Credit Suisse
MD
2021GLAXOSMITHKLINE : Barclays keeps a Sell rating
MD
2021GLAXOSMITHKLINE : Goldman Sachs keeps its Buy rating
MD
2021GLAXOSMITHKLINE : JP Morgan reiterates its Neutral rating
MD
2021GLAXOSMITHKLINE : Receives a Buy rating from Jefferies
MD
2021GLAXOSMITHKLINE : Berenberg Slashes GlaxoSmithKline's PT, Keeps Rating
MT
2021GLAXOSMITHKLINE : Berenberg Maintains GlaxoSmithKline At Buy, Trims PT
MT
2021ANALYST RECOMMENDATIONS : Drax, GlaxoSmithKline, Goldman Sachs, JP Morgan, Steel Dynamics...
2021GLAXOSMITHKLINE : JP Morgan reiterates its Neutral rating
MD
2021GLAXOSMITHKLINE : Receives a Buy rating from Berenberg
MD
2021GLAXOSMITHKLINE : Goldman Sachs remains its Buy rating
MD
2021GLAXOSMITHKLINE : Morgan Stanley Drops GlaxoSmithKline's PT, Keeps Equal-Weight Rating
MT
2021GLAXOSMITHKLINE : Morgan Stanley remains Neutral
MD
2021GLAXOSMITHKLINE : UBS sticks Neutral
MD
2021GLAXOSMITHKLINE : JP Morgan gives a Neutral rating
MD
2021GLAXOSMITHKLINE : UBS sticks Neutral
MD
2021GLAXOSMITHKLINE : UBS Trims GlaxoSmithKline PT, Keeps Neutral Rating
MT
2021GLAXOSMITHKLINE : UBS gives a Neutral rating
MD
2021GLAXOSMITHKLINE : Deutsche Bank reiterates its Neutral rating
MD
2021GLAXOSMITHKLINE : UBS Hikes GlaxoSmithKline's PT, Maintains Neutral Rating
MT
2021GLAXOSMITHKLINE : UBS sticks Neutral
MD
2021GLAXOSMITHKLINE : Berenberg reiterates its Buy rating
MD
2021GLAXOSMITHKLINE : Goldman Sachs reiterates its Buy rating
MD
2021GLAXOSMITHKLINE : UBS Cuts GlaxoSmithKline PT, Maintains Neutral Rating
MT
2021GLAXOSMITHKLINE : UBS sticks Neutral
MD
2021GLAXOSMITHKLINE : Credit Suisse keeps a Sell rating
MD
2021GLAXOSMITHKLINE : Barclays Lifts GlaxoSmithKline PT, Maintains Underweight Rating
MT
2021GLAXOSMITHKLINE : Barclays reiterates its Sell rating
MD
2021GLAXOSMITHKLINE : UBS reiterates its Neutral rating
MD
2021GLAXOSMITHKLINE : Deutsche Bank remains Neutral
MD
2021GLAXOSMITHKLINE : JP Morgan reaffirms its Neutral rating
MD
2021GLAXOSMITHKLINE : Receives a Buy rating from Jefferies
MD
2021GLAXOSMITHKLINE : Goldman Sachs reiterates its Buy rating
MD
2021ANALYST RECOMMENDATIONS : Barclays, Chevron, Flutter, Netflix, Unilever...
2021GLAXOSMITHKLINE : JP Morgan reiterates its Neutral rating
MD
2021GLAXOSMITHKLINE : UBS reiterates its Neutral rating
MD
2021ANALYST RECOMMENDATIONS : GlaxoSmithKline, Qualcomm, State Street, Tate & Lyle, Virgin Mon..
2021GLAXOSMITHKLINE : Barclays keeps a Sell rating
MD
1  2  3  4  5  6Next
Upcoming event on GLAXOSMITHKLINE PLC
02/09/22